A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial Conjunctivitis

• Status: Completed
• Trial end date: 2009-01-01
• Target enrollment: 0
• Participant gender: All

Summary

The study will determine the safety and efficacy of gatifloxacin eye drops in patients with bacterial conjunctivitis

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Fluoroquinolones; Gatifloxacin; Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

• Clinically diagnosed with bacterial conjunctivitis

Exclusion Criteria:

• Signs and/or symptoms of conjunctivitis for more than 96 hours

• Signs and/or symptoms suggestive of fungal, viral, or allergic conjunctivitis

• Clinical diagnosis of chlamydia in either eye